Edmond DE Rothschild Holding S.A. Buys 590 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Edmond DE Rothschild Holding S.A. lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,288 shares of the exchange traded fund’s stock after buying an additional 590 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in SPDR S&P Biotech ETF were worth $296,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares in the last quarter. Ameritas Advisory Services LLC raised its holdings in SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after acquiring an additional 1,137 shares in the last quarter. Van ECK Associates Corp bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $1,497,000. Parallel Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Runnymede Capital Advisors Inc. bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $160,000.

SPDR S&P Biotech ETF Stock Up 3.1 %

XBI stock opened at $80.59 on Thursday. The company has a market cap of $5.08 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 52 week low of $77.26 and a 52 week high of $105.47. The business has a 50-day simple moving average of $88.81 and a 200 day simple moving average of $93.53.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.